Skip to main content
. 2013 Dec 13;7:254. doi: 10.3389/fncel.2013.00254

Figure 1.

Figure 1

Olig2 expression in the human fetal forebrain. (A) Schematic representation of the distribution of Olig2+ cells (red dots) in frontal sections of the fetal (5–19 gw) and neonatal human telencephalon. (B) Representative Olig2 (green) immunostaining in 15 gw fetal forebrain. Nuclear staining with bisbenzimide (BB) in blue. (C) RT-PCR levels for mRNA Olig2 in CX and GE in 16–18 gw human brains. Data are presented as mean ± standard deviation. (D) Percentage of Olig2+ cells in ventral (GE) and cortical (CX) cultures. Data are presented as mean ± s.e.m. (9 optical fields quantified in each culture). *p < 0.05, **p < 0.01 vs. control; ##p < 0.01- GE vs. CX. Scale bar: 20 μm. CC, Corpus Callosum; CP, Cortical Plate; IC, Internal Capsule; IZ, Intermediate Zone; LGE, Lateral Ganglionic Eminence; LV, Lateral Ventricle; MGE, Medial Ganglionic Eminence; OV, Optical Vesicle; SP, Subplate layer; TH, Thalamus; VZ/SVZ, Ventricular/Subventricular Zone.

HHS Vulnerability Disclosure